Pharmacogene Variation Consortium
From Wikipedia, the free encyclopedia
Pharmacogene Variation Consortium (abbreviated as PhamVar) is an international group of experts that maintains a systematic nomenclature system for allelic variations of genes that affect the metabolism of drugs.[1][2]
DescriptionThe PharmVar Consortium
Data types
capturedPharmacogenomics and Pharmacogenetics
capturedPharmacogenomics and Pharmacogenetics
OrganismsHuman
 | |
| Content | |
|---|---|
| Description | The PharmVar Consortium |
| Data types captured | Pharmacogenomics and Pharmacogenetics |
| Organisms | Human |
| Contact | |
| Research center | Children's Mercy Hospital |
| Primary citation | PMID 29134625 |
| Release date | 2017 |
| Access | |
| Website | www |
| Download URL | www |
| Web service URL | www |
| Miscellaneous | |
| Curation policy | Yes |
The database is focused on cytochrome P450 enzymes, but is being expanded into other classes of enzymes. The original nomenclature was maintained by the Human CYP Allele Nomenclature Database. However PhamVar took over this function in 2017.[3]